23
total announcements
544091.BO · 15 min delayed
Qualitek Labs Ltd
Qualitek Labs Ltd has announced the resignation of Mr. Ajay Agarwal as Non-Executive Independent Director due to personal reasons, effective October 29, 2026.
Qualitek Labs Ltd
Qualitek Labs Ltd's independent director, Ajay Agarwal, has resigned due to personal reasons, effective from 29th October 2026. The resignation is not related to any material reasons or committee memberships.
Qualitek Labs Ltd
Qualitek Labs Ltd's wholly owned subsidiary, Interstellar Testing Centre Private Limited, has received a work order from Bio-Resources Development Centre (BRDC), Government of Meghalaya, for setting up, operating, and accrediting a Quality Control and Analytical Laboratory.
Qualitek Labs Ltd
Qualitek Labs Ltd's wholly owned subsidiary, Interstellar Testing Centre Private Limited, has received a work order from Bio-Resources Development Centre (BRDC), Government of Meghalaya, for setting up, operating, and accrediting a Quality Control and Analytical Laboratory.
Qualitek Labs Ltd
Qualitek Labs Ltd has announced the E-voting results and Scrutinizer report for its Extra-Ordinary General Meeting held on October 16, 2026, where two resolutions were passed, including the issuance of 3,86,000 equity shares and up to 5,20,000 fully convertible warrants on a preferential basis.
Qualitek Labs Ltd
Qualitek Labs Ltd held an Extra-Ordinary General Meeting (EGM) on October 16, 2026, where two special resolutions were passed: issuance of 3,86,000 equity shares on a preferential basis and issuance of up to 5,20,000 fully convertible warrants to promoter and promoter group entities.
Qualitek Labs Ltd
Qualitek Labs Ltd held an Extra-Ordinary General Meeting (EGM) on October 16, 2026, through Video Conferencing, where two resolutions were passed: issuance of 386,000 equity shares on a preferential basis and issuance of up to 520,000 fully convertible warrants on a preferential basis.
Qualitek Labs Ltd
Qualitek Labs Ltd has issued a corrigendum to the notice of an Extra-Ordinary General Meeting (EGM) scheduled for October 16, 2026, to provide clarifications and amendments in relation to the shareholding pattern disclosed in the Explanatory Statement.
Qualitek Labs Ltd
Qualitek Labs Ltd has submitted a compliance certificate under Regulation 74(5) of SEBI (DP) Regulations, 2018 for the quarter ended September 30, 2026, confirming compliance with the provisions of the regulation.
Qualitek Labs Ltd
Qualitek Labs Ltd has announced the closure of its trading window from October 1, 2026, until 48 hours after the declaration of its unaudited financial results for the quarter and half year ended September 30, 2026, as per SEBI regulations.
Qualitek Labs Ltd
Qualitek Labs Ltd has announced the voting results and Scrutinizer's Report for its 8th Annual General Meeting, which was held on September 25, 2026. The meeting was attended by 932 shareholders, and the voting results have been made available on the company's website.
Qualitek Labs Ltd
Qualitek Labs Ltd held its 8th Annual General Meeting on September 25, 2026, where the company adopted its audited standalone and consolidated financial statements for the financial year ended March 31, 2026, and re-appointed its Managing Director & CEO, Antaryami Nayak, for another term. The company also approved material related party transactions for the financial year 2026-27.
Qualitek Labs Ltd
Qualitek Labs Ltd has informed the Exchange regarding the Newspaper Publication w.r.t. dispatch of Notice of Extra Ordinary General Meeting to be held on October 16, 2026.
Qualitek Labs Ltd
Qualitek Labs Ltd has informed the Exchange regarding the Notice of the Extra Ordinary General Meeting to be held on October 16, 2026, to consider issuance of equity shares on a preferential basis to the persons belonging to the promoter/promoter group and non-promoter category/strategic investors.
Qualitek Labs Ltd
Qualitek Labs Ltd has informed the BSE about the outcome of the Preferential Issue Committee meeting, where they approved the substitution of one proposed allottee in the proposed Preferential Issue.
Qualitek Labs Ltd
Qualitek Labs Ltd has informed the exchange about the issuance of equity shares and fully convertible warrants on a preferential basis. The company has approved the issuance of up to 3,86,000 equity shares and up to 5,20,000 fully convertible warrants to the proposed allottees, including promoters and non-promoters, at an issue price of ₹518.55 per equity share.
Qualitek Labs Ltd
Qualitek Labs Ltd has published a notice for its 8th Annual General Meeting (AGM) and e-voting details in newspapers and on its website.
Qualitek Labs Ltd
Qualitek Labs Ltd has announced its Integrated Annual Report for the Financial Year 2025-26, along with the Notice convening the 8th Annual General Meeting. The report includes financial highlights, business updates, CSR initiatives, and statutory reports. The AGM is scheduled to be held on September 25, 2026, and members can cast their votes through remote e-voting or polling facility.
Qualitek Labs Ltd
Qualitek Labs Ltd has announced the 8th Annual General Meeting (AGM) to be held on September 25, 2026, at Avanta Business Centre, New Delhi. The AGM will consider various resolutions, including the appointment of directors, auditor, and the ratification of the management's remuneration. The company has also released its Integrated Annual Report for the Financial Year 2025-26.
Qualitek Labs Ltd
Qualitek Labs Ltd has announced the details of its 8th Annual General Meeting (AGM), including remote e-voting and cut-off date, as per SEBI (LODR) Regulations, 2015.